首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality.
【24h】

Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality.

机译:与年轻的腹膜透析患者相比,老年患者的无腹膜炎生存率相似,技术失败的风险较低,但与腹膜炎相关的死亡风险较高。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The number of elderly patients with end-stage kidney disease (ESKD) is increasing worldwide, but the proportion of elderly patients commencing peritoneal dialysis (PD) is falling. The reluctance of elderly ESKD patients to consider PD may be related to a perception that PD is associated with greater rates of complications. In the present study, we compared outcomes between younger and older PD patients. METHODS: Using Australia and New Zealand Dialysis Registry data, all adult ESKD patients commencing PD between 1991 and 2007 were categorized into under 50, 50 - 64.9, and 65 years of age or older groups. Time to first peritonitis, death-censored technique failure, and peritonitis-associated and all-cause mortality were evaluated by multivariate Cox proportional hazards model analysis. RESULTS: Of the 12 932 PD patients included in the study, 3370 (26%) were under 50 years of age, 4386 (34%) were 50 - 64.9 years of age, and 5176 (40%) were 65 years of age or older. Compared with younger patients (<50 years), elderly patients (>/= 65 years) had a similar peritonitis-free survival and a lower risk of death-censored technique failure [hazard ratio (HR): 0.85; 95% confidence interval (CI): 0.79 to 0.93], but they had higher peritonitis-related (HR: 2.31; 95% CI: 1.68 to 3.18) and all-cause mortality (HR: 2.90; 95% CI: 2.60 to 3.23). CONCLUSIONS: Not unexpectedly, elderly patients have higher peritonitis-related and all-cause mortality, which is likely a consequence of a greater prevalence of comorbid disease. However, compared with younger patients, elderly patients have superior technique survival and similar peritonitis-free survival, suggesting that PD is a viable renal replacement therapy in this group of patients.
机译:背景:全球范围内患有晚期肾病(ESKD)的老年患者的数量正在增加,但是开始进行腹膜透析(PD)的老年患者的比例正在下降。老年ESKD患者不愿考虑PD可能与以下观点有关:PD与更高的并发症发生率相关。在本研究中,我们比较了年轻和老年PD患者之间的结局。方法:使用澳大利亚和新西兰透析注册中心的数据,将1991年至2007年之间所有开始PD的成人ESKD患者分为50岁以下,50岁至64.9岁以及65岁以上的年龄组。通过多变量Cox比例风险模型分析评估了首次发生腹膜炎的时间,以死亡检查的技术失败以及与腹膜炎相关的和全因死亡率。结果:纳入研究的12932名PD患者中,有3370名(26%)年龄在50岁以下,4386名(34%)年龄在50-64.9岁之间,5176名(40%)在65岁以下。年长的。与年轻患者(<50岁)相比,老年患者(> / = 65岁)的无腹膜炎生存率相似,而以死亡为前提的技术失败的风险较低[危险比(HR):0.85; 95%置信区间(CI):0.79至0.93],但他们的腹膜炎相关性更高(HR:2.31; 95%CI:1.68至3.18)和全因死亡率(HR:2.90; 95%CI:2.60至3.23) )。结论:并非意外的是,老年患者具有较高的腹膜炎相关性和全因死亡率,这很可能是合并症发病率更高的结果。但是,与年轻患者相比,老年患者具有更高的技术生存率和类似的无腹膜炎生存率,这表明PD是这类患者中可行的肾脏替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号